BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Johnson and Johnson
Merck
Queensland Health
Citi
Express Scripts
US Department of Justice
Covington
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

PRAMINE Drug Profile

« Back to Dashboard

Which patents cover Pramine, and what generic alternatives are available?

Pramine is a drug marketed by Alra and is included in one NDA.

The generic ingredient in PRAMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.

US Patents and Regulatory Information for PRAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra PRAMINE imipramine hydrochloride TABLET;ORAL 083827-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alra PRAMINE imipramine hydrochloride TABLET;ORAL 083827-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alra PRAMINE imipramine hydrochloride TABLET;ORAL 083827-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cipla
Accenture
Healthtrust
Deloitte
Baxter
Cerilliant
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot